Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies.

4 A randomized control trial that was halted before completing enrollment for different reasons, including slow accrual, showed a trend towards a lower rate of progression to LRTI when aerosolized ribavirin was used. 71 Of the nine patients who were treated with ribavirin, only one experienced progression compared to two of the five patients who were not treated.

also in 53,322 other papers

Although some of these studies showed a positive trend towards a benefit from therapy with ribavirin, specific recommendations cannot be made at present.

also in 11,005 other papers